Stimuli-responsive prodrug-based cancer nanomedicine.
Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, Qi B, Patel D, Shi B, Tao W.
Xie A, et al. Among authors: qi b.
EBioMedicine. 2020 Jun;56:102821. doi: 10.1016/j.ebiom.2020.102821. Epub 2020 Jun 7.
EBioMedicine. 2020.
PMID: 32505922
Free PMC article.
Review.